X0206 3 2018-12-07 0 0001682852 Moderna, Inc. MRNA 0001690927 Zaks Tal Zvi C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 0 1 0 0 Chief Medical Officer Common Stock 204770 D Stock Option (Right to Buy) 19.15 2026-08-10 Common Stock 483302 D Stock Option (Right to Buy) 12.21 2027-02-23 Common Stock 183486 D Stock Option (Right to Buy) 12.21 2027-10-03 Common Stock 458715 D Stock Option (Right to Buy) 14.22 2028-02-28 Common Stock 160550 D The 204,770 shares reported in this column are subject to a restricted stock grant dated August 10, 2016, which vests as follows: 25% of the Shares to vest on the first anniversary of the vest start date of March 16, 2015, and the remainder vests in 12 quarterly installments. 25% of this option vested and became exercisable on March 16, 2016, with the remainder vesting in 12 equal quarterly installments thereafter. 25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter. 229,358 of the options will vest over 4 years (25% on the first anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 137,614 of the options will vest over 5 years (25% on the second anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 91,743 of the options will vest over 6 years (25% on the third anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 25% of this option will vest and become exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter. Exhibit 24.1: Power of Attorney /s/ Jeffrey Cerio, as Attorney-in-Fact 2018-12-07